David Fabregat's Avatar

David Fabregat

@davidfabregat

PostDoc Researcher in Analytical Chemistry at Applied Metabolomics research group (@researchmar.bsky.social) and collaborator at Research Institute for Pesticides and Waters (@uji.es). #MassSpec #Metabolomics ORCID: https://orcid.org/0000-0002-2918-227X

46
Followers
215
Following
8
Posts
28.01.2025
Joined
Posts Following

Latest posts by David Fabregat @davidfabregat

πŸ“œIt has been a pleasure to collaborate in this highly interesting study published in @commsbio.nature.com!

πŸŽ‰Congrats @gmallaret.bsky.social and colleagues!

πŸ”œAnd more to come from the collaboration bewteen Laetitia Davidovic's research group and Applied Metabolomics at @researchmar.bsky.social.

25.11.2025 07:24 πŸ‘ 3 πŸ” 1 πŸ’¬ 0 πŸ“Œ 0

πŸ‘ Future works should ideally satisfy all the steps outlined to ensure confidence in the metabolites found to be significant for a specific cancer . They should clearly indicate their limitations by specifying the workflow steps completed and those that require further research.

24.11.2025 11:15 πŸ‘ 0 πŸ” 0 πŸ’¬ 0 πŸ“Œ 0

πŸ€” The analytical laboratories working on MS-based metabolomics for clinical applications should consider that they are providing crucial data for medical researchers, being aware of the need of providing robust results to cancer research.

24.11.2025 11:15 πŸ‘ 0 πŸ” 0 πŸ’¬ 1 πŸ“Œ 0

πŸ’‘ With the main objective of favouring the standardization, we propose a workflow for the establishment of cancer biomarkers which includes different pivotal steps and issues that must be carefully evaluated for maximizing robustness and reliability on the proposed biomarkers.

24.11.2025 11:15 πŸ‘ 0 πŸ” 0 πŸ’¬ 1 πŸ“Œ 0

πŸ“œ One of the key aspects is the need for a consensus in MS-based metabolomics for the discovery of clinical biomarkers and their implementation for the early-diagnosis of cancer.

24.11.2025 11:15 πŸ‘ 0 πŸ” 0 πŸ’¬ 1 πŸ“Œ 0

πŸ“ In this study, we identified the most critical aspects of the metabolomics workflow that should be carefully addressed in future mass spectrometry-based metabolomics studies in cancer diagnosis.

24.11.2025 11:15 πŸ‘ 0 πŸ” 0 πŸ’¬ 1 πŸ“Œ 0

🀝 This thorough and critical review of the MS-based metabolomics studies for cancer biomarker of the last 7 years has been possible thanks to the strong collaboration, passion and dedication of different researchers from Applied #Metabolomics research group and @researchmar.bsky.social.

24.11.2025 11:15 πŸ‘ 0 πŸ” 0 πŸ’¬ 1 πŸ“Œ 0
Preview
Lights and shadows of mass spectrometry-based metabolomics studies in cancer diagnosis: is there any marker beyond the literature background noise? Mass spectrometry (MS)-based metabolomics is considered as one of the gold-standards for the discovery of clinical biomarkers. However, metabolites pr…

πŸ“’ NEW PUBLICATION ALERT!!

😍 I'm extremely glad to share with all of you our new publication in TrAC-Trends in Analytical Chemistry
@elsevierconnect.bsky.social.

🌐 Feel free to download the publication (open access) from the folllowing link: sciencedirect.com/science/arti...

🧡 Summary thread:

24.11.2025 11:15 πŸ‘ 5 πŸ” 0 πŸ’¬ 1 πŸ“Œ 0